Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The effect of latanoprost and influence of changes in body position on patients with glaucoma and ocular hypertension.

Steigerwalt RD Jr, Vingolo EM, Plateroti P, Nebbioso M.

Eur Rev Med Pharmacol Sci. 2012 Nov;16(12):1723-8.

2.
3.

Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.

Uva MG, Longo A, Reibaldi M.

Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1103-9. doi: 10.1007/s00417-009-1055-0. Epub 2009 Feb 27.

PMID:
19247684
4.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886
6.

A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.

Susanna R Jr, Giampani J Jr, Borges AS, Vessani RM, Jordao ML.

Ophthalmology. 2001 Feb;108(2):259-63.

PMID:
11158796
7.

A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension.

Tsukamoto H, Mishima HK, Kitazawa Y, Araie M, Abe H, Negi A; Glaucoma Study Group.

J Glaucoma. 2002 Dec;11(6):497-501.

PMID:
12483094
8.
9.

Effects of latanoprost 50 micrograms/ml on Chinese patients with primary open-angle glaucoma and ocular hypertension.

Liu CJ, Chou JC, Hsu WM, Liu JH.

Zhonghua Yi Xue Za Zhi (Taipei). 1999 Oct;62(10):703-9.

PMID:
10533300
10.

Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.

Kałuzny J, Sobecki R, Czechowicz-Janicka K, Kecik D, Kałuzny BJ, Stewart JA, Stewart WC.

Acta Ophthalmol. 2008 Dec;86(8):860-5. doi: 10.1111/j.1755-3768.2008.01324.x. Epub 2008 Aug 20.

11.
12.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
13.
14.

Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.

Koz OG, Ozsoy A, Yarangumeli A, Kose SK, Kural G.

Acta Ophthalmol Scand. 2007 Dec;85(8):838-43. Epub 2007 Aug 2.

15.

Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.

Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2566-73.

PMID:
10937568
16.
17.

Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study.

Shoji N, Ogata H, Suyama H, Ishikawa H, Suzuki H, Morita T, Kawai H, Nishimoto H, Nemoto T, Shimizu K.

Curr Med Res Opin. 2005 Apr;21(4):503-8.

PMID:
15899098
19.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Oct;132(4):472-84.

PMID:
11589866
20.

Latanoprost 0.005% test formulation is as effective as Xalatan® in patients with ocular hypertension and primary open-angle glaucoma.

Allaire C, Dietrich A, Allmeier H, Grundmane I, Mazur-Piotrowska G, Neshev P, Kahle G.

Eur J Ophthalmol. 2012 Jan-Feb;22(1):19-27. doi: 10.5301/ejo.5000041.

PMID:
22167539
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk